Word: requip
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Currently, there are two drugs approved to treat RLS. One of the drugs, Requip, made $500 million last year for the pharmaceutical company GlaxoSmithKline, which first marketed the drug in 1997 for Parkinson's disease. Today, the company markets Requip - some say aggressively - as a treatment for RLS. It is now prescribed more often to treat that condition than Parkinson's, Rye says. Experts who challenge the validity of RLS say that such drug-company advertising campaigns over-medicalize phantom conditions and drive people to take drugs they don't need...
...just a nervous foot-tapper, yet hearing the term on television, seeing the advertisement for treatment and searching on the term, I could be easily convinced I had the disease. According to search term data, searches on the condition reached their peak soon after the FDA approved requip in May of 2005, one of the first drugs targeted specifically at the condition...
...population and can cause nagging pain and discomfort along with an uncontrollable urge to move one's legs during periods of physical inactivity. At night it can mean hundreds of jerky, involuntary movements and can result in chronic sleep deprivation. A study reported in the journal Sleep found that Requip, a drug for Parkinson's disease, significantly reduced RLS symptoms and improved the quality of sleep. The drug is currently being reviewed for approval by the FDA. --By David Bjerklie
| 1 |